Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CStone Pharmaceuticals Co. Ltd.

http://www.cstonepharma.com

Latest From CStone Pharmaceuticals Co. Ltd.

EQRx Raises White Flag On Its Low-Cost Drug Business Model

The company is backing out of the development of several clinical-stage assets and will cut 170 positions while it changes its business strategy.

Business Strategies Clinical Trials

Opportunities Amid Crisis: Junshi, Allist Look To Expand Pipelines Through Alliances, M&A

Against the prevailing headwinds in the biotech sector, two Chinese firms are bucking the trend of pipeline reorganization by eyeing the potential acquisition of assets from external partners to expand into more modalities and therapeutic areas.

China M & A

Chinese ADC Developers Catch Up with Global Players In Advancing Key Payloads

Chinese pharma firms led by Kelun are moving fast to develop the next-generation of cytotoxic "warheads," a key component of antibody-drug conjugates, disclosed company executives at conference in Suzhou.

China Research & Development

Novel Anti-Hypertensive Treatment & NSCLC Drug Among New EU Filings

The European Medicines Agency has added five new drugs to its latest monthly list of medicines that are under review for potential EU marketing approval.

Europe Drug Review
See All

Company Information

UsernamePublicRestriction

Register